Novartis' Lamisil (terbinafine) generated sales of $978m in 2006 but the same drug has, in rare cases caused liver failure. These have resulted in the need ...
The market for Lamisil(R) exceeds $800 million. Breckenridge signed a Letter of Intent in February 2007 to secure the marketing in the US for the ANDA; ...
The market for Lamisil(R) exceeds $800 million. Breckenridge signed a Letter of Intent in February 2007 to secure the marketing in the US for the ANDA; ...
Novartis' Lamisil (terbinafine) generated sales of $978m in 2006 but the same drug has, in rare cases caused liver failure. These have resulted in the need ...